Advertisement
Advertisement

LIVN

LIVN logo

LivaNova PLC Ordinary Shares

71.86
USD
Sponsored
+0.94
+1.32%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

71.86

0.00
0.00%

LIVN Earnings Reports

Positive Surprise Ratio

LIVN beat 34 of 41 last estimates.

83%

Next Report

Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$387.32M
/
$1.11
Implied change from Q1 26 (Revenue/ EPS)
+6.91%
/
+13.27%
Implied change from Q2 25 (Revenue/ EPS)
+9.88%
/
+5.71%

LivaNova PLC Ordinary Shares earnings per share and revenue

On May 06, 2026, LIVN reported earnings of 0.98 USD per share (EPS) for Q1 26, beating the estimate of 0.91 USD, resulting in a 7.14% surprise. Revenue reached 362.30 million, compared to an expected 353.03 million, with a 2.63% difference. The market reacted with a +15.05% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 10 analysts forecast an EPS of 1.11 USD, with revenue projected to reach 387.32 million USD, implying an increase of 13.27% EPS, and increase of 6.91% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Teleflex Incorporated
Report Date
May 07, 2026 For Q1 26
Estimate
$1.22
Actual
$1.39
Surprise
+13.68%
logo
Mettler-Toledo International
Report Date
May 07, 2026 For Q1 26
Estimate
$8.78
Actual
$8.91
Surprise
+1.37%
logo
GLOBUS MEDICAL INC
Report Date
May 07, 2026 For Q1 26
Estimate
$0.93
Actual
$1.12
Surprise
+19.39%
logo
Artivion, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.05
Actual
$0.08
Surprise
+59.68%
logo
Tandem Diabetes Care, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.45
Actual
-$0.30
Surprise
+34.01%
logo
Pacific Biosciences of California, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.12
Surprise
+12.73%
logo
Delcath Systems Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
-$0.03
Surprise
+66.06%
logo
EDAP TMS SA
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.24
Surprise
-25.59%
logo
Treace Medical Concepts, Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.28
Surprise
+10.88%
logo
Sensus Healthcare, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.16
Surprise
-25.49%
FAQ
For Q1 2026, LivaNova PLC Ordinary Shares reported EPS of $0.98, beating estimates by 7.14%, and revenue of $362.30M, 2.63% above expectations.
The stock price moved up 15.05%, changed from $57.59 before the earnings release to $66.26 the day after.
The next earning report is scheduled for Aug 04, 2026.
Based on 10 analysts, LivaNova PLC Ordinary Shares is expected to report EPS of $1.11 and revenue of $387.32M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement